» Articles » PMID: 36270786

Severity of Obstructive Coronary Artery Stenosis After Pre-eclampsia

Overview
Journal Heart
Date 2022 Oct 21
PMID 36270786
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Women with a history of pre-eclampsia are at higher risk of premature coronary artery disease. Assessment of obstructive coronary artery stenosis by invasive coronary angiography has not been evaluated after pre-eclampsia.

Methods: A population-based cohort study was completed in Ontario, Canada, where there is universal healthcare and collection of angiographic data. Included were women with a live birth or stillbirth from 2002 to 2020, and without known heart disease. One birth was randomly selected per woman. The main exposure compared women with versus without pre-eclampsia. The primary outcome was angiographically established obstructive coronary artery stenosis, assessed starting 42 days after the index birth. Cause-specific hazard models accounting for competing risks generated HRs, adjusted for age, parity, income, rurality, diabetes, chronic hypertension, renal disease, substance use and dyslipidaemia.

Results: Among 42 252 women ever with pre-eclampsia and 1359 122 never with pre-eclampsia, mean age was 31.1 years and 30.6 years, respectively. After 9 years of follow-up, obstructive coronary artery stenosis occurred in 186 women with pre-eclampsia (4.53 per 10 000 person-years) versus 1237 women without pre-eclampsia (0.97 per 10 000 person-years)-an unadjusted HR 4.41 (95% CI 3.78 to 5.14) and adjusted HR 2.07 (95% CI 1.77 to 2.43). Relative to those with neither, the adjusted HR for coronary stenosis was highest in women with pre-eclampsia and preterm birth (3.11, 95% CI 2.51 to 3.87), or pre-eclampsia and stillbirth (2.80, 95% CI 1.05 to 7.47).

Conclusions: Pre-eclampsia is associated with a greater risk of premature-onset obstructive coronary artery stenosis, especially when it is complicated by a preterm birth or a stillbirth.

Citing Articles

Trained innate immunity as a potential link between preeclampsia and future cardiovascular disease.

Carrasco-Wong I, Sanchez J, Gutierrez J, Chiarello D Front Endocrinol (Lausanne). 2025; 15:1500772.

PMID: 39741876 PMC: 11685753. DOI: 10.3389/fendo.2024.1500772.


Cardiovascular risk management following gestational diabetes and hypertensive disorders of pregnancy: a narrative review.

Marschner S, Pant A, Henry A, Maple-Brown L, Moran L, Cheung N Med J Aust. 2023; 218(10):484-491.

PMID: 37149790 PMC: 10953444. DOI: 10.5694/mja2.51932.

References
1.
Langlois A, Park A, Lentz E, Ray J . Preeclampsia Brings the Risk of Premature Cardiovascular Disease in Women Closer to That of Men. Can J Cardiol. 2019; 36(1):60-68. DOI: 10.1016/j.cjca.2019.06.028. View

2.
Catov J, Muldoon M, Gandley R, Brands J, Hauspurg A, Hubel C . Maternal Vascular Lesions in the Placenta Predict Vascular Impairments a Decade After Delivery. Hypertension. 2021; 79(2):424-434. PMC: 9026545. DOI: 10.1161/HYPERTENSIONAHA.121.18394. View

3.
Austin P, Fine J . Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med. 2017; 36(27):4391-4400. PMC: 5698744. DOI: 10.1002/sim.7501. View

4.
Heidenreich P, Lin S, Knowles J, Perez M, Maddox T, Ho M . Variation in use of left ventriculography in the Veterans Affairs Health Care System. Circ Cardiovasc Qual Outcomes. 2013; 6(6):687-93. DOI: 10.1161/CIRCOUTCOMES.113.000199. View

5.
Ko D, Tu J, Austin P, Wijeysundera H, Samadashvili Z, Guo H . Prevalence and extent of obstructive coronary artery disease among patients undergoing elective coronary catheterization in New York State and Ontario. JAMA. 2013; 310(2):163-9. DOI: 10.1001/jama.2013.7834. View